Related references
Note: Only part of the references are listed.From the bench to the clinic and back again:: translational biomarker discovery using in silico mining of pharmacogenomic data
Donna L. Mendrick et al.
BIOMARKERS IN MEDICINE (2007)
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity
Michaela Adamcova et al.
TOXICOLOGY (2007)
Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure
Orfeas Liangos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Dual action of neutrophil gelatinase-associated lipocalin
Kai M. Schmidt-Ott et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury
Richard A. Zager et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
The Pharmacogenetics Research Network: From SNP discovery to clinical drug response
K. M. Giacomini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Early prediction of anthracycline induced cardiotoxicity
Bedirhan Erkus et al.
ACTA PAEDIATRICA (2007)
Tubular kidney injury molecule-1 (KIM-1) in human renal disease
M. M. van Timmeren et al.
JOURNAL OF PATHOLOGY (2007)
Noninvasive tests for liver fibrosis
Sandeep Mukherjee et al.
SEMINARS IN LIVER DISEASE (2006)
Mechanistic biomarkers for cytotoxic acute kidney injury
Vishal S. Vaidya et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Toxicogenomics strategies for predicting drug toxicity
Rory Martin et al.
PHARMACOGENOMICS (2006)
Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes
L. Hultin-Rosenberg et al.
XENOBIOTICA (2006)
The intersection of biotechnology and pharmacogenomics: Health policy implications
Kathryn A. Phillips
HEALTH AFFAIRS (2006)
The exciting story of cardiac biomarkers: From retrospective detection to gold diagnostic standard for acute myocardial infarction and more
A. Dolci et al.
CLINICA CHIMICA ACTA (2006)
Biomarkers in acute cardiac disease - The present and the future
Allan S. Jaffe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Process map proposal for the validation of genomic biomarkers
Federico Goodsaid et al.
PHARMACOGENOMICS (2006)
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine
Sarah E. McDowell et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney
TM El-Achkar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Pharmacogenetics of irinotecan metabolism and transport: An update
NF Smith et al.
TOXICOLOGY IN VITRO (2006)
Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury
VS Vaidya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2
S Fries et al.
GASTROENTEROLOGY (2006)
Pharmacogenetics and the concept of individualized medicine
BS Shastry
PHARMACOGENOMICS JOURNAL (2006)
Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker
Peter James O'Brien
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety
Amber L. Beitelshees et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Serum chemical biomarkers of cardiac injury for nonclinical safety testing
DB Walker
TOXICOLOGIC PATHOLOGY (2006)
Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
AM Larson et al.
HEPATOLOGY (2005)
Drug-induced torsades de pointes: The evolving role of pharmacogenetics
PT Fitzgerald et al.
HEART RHYTHM (2005)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Measuring the value of pharmacogenomics
KA Phillips et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
The economic implications of noninvasive molecular testing for cardiac allograft rejection
RW Evans et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Drug-induced vascular injury - a quest for biomarkers
W Kerns et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Liver enzyme alteration: a guide for clinicians
EG Giannini et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity
MR Fielden et al.
TOXICOLOGIC PATHOLOGY (2005)
Identification of putative gene-based markers of renal toxicity
RA Amin et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
GP Aithal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity
JW Davis et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
KA Phillips et al.
PHARMACOGENOMICS (2004)
Pharmacogenetic aspects of drug-induced torsade de pointes - Potential tool for improving clinical drug development and prescribing
RR Shah
DRUG SAFETY (2004)
Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity
J Mishra et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Serum troponins as biomarkers of drug-induced cardiac toxicity
KB Wallace et al.
TOXICOLOGIC PATHOLOGY (2004)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
WK Han et al.
KIDNEY INTERNATIONAL (2002)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats
T Nakamura et al.
HEPATOLOGY (2000)
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
H Okumura et al.
ACTA HAEMATOLOGICA (2000)
Share Paper
